D-amino acid-containing supramolecular nanofibers for potential cancer therapeutics

Abstract

Nanostructures formed by peptides that self-assemble in water through non-covalent interactions have attracted considerable attention because peptides possess several unique advantages, such as modular design and easiness of synthesis, convenient modification with known functional motifs, good biocompatibility, low immunogenicity and toxicity, inherent biodegradability, and fast responses to a wide range of external stimuli. After about two decades of development, peptide-based supramolecular nanostructures have already shown great potentials in the fields of biomedicine. Among a range of biomedical applications, using such nanostructures for cancer therapy has attracted increased interests since cancer remains the major threat for human health. Comparing with L-peptides, nanostructures containing peptides made of D-amino acid (i.e., D-peptides) bear a unique advantage, biostability (i.e., resistance towards most of endogenous enzymes). The exploration of nanostructures containing D-amino acids, especially their biomedical applications, is still in its infancy. Herein we review the recent progress of D-amino acid-containing supramolecular nanofibers as an emerging class of biomaterials that exhibit unique features for the development of cancer therapeutics. In addition, we give a brief perspective about the challenges and promises in this research direction.

Keywords: 10-Hydroxycamptothecin (PubChem CID: 97226); 4-Chloro-7-nitrobenzofurazan (PubChem CID: 25043); Cancer therapeutics; D-amino acid; D-peptide; Dapi (PubChem CID: 2954); Multifaceted; Nanofibers; O-Phospho-L-tyrosine (PubChem CID: 30819); Paclitaxel (PubChem CID: 36314); System biology; Taurine (PubChem CID: 1123).